1. Academic Validation
  2. BCL6 positively regulates AID and germinal center gene expression via repression of miR-155

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155

  • J Exp Med. 2012 Dec 17;209(13):2455-65. doi: 10.1084/jem.20121387.
Katia Basso 1 Christof Schneider Qiong Shen Antony B Holmes Manu Setty Christina Leslie Riccardo Dalla-Favera
Affiliations

Affiliation

  • 1 Institute for Cancer Genetics, Columbia University, New York, NY 10027, USA. [email protected]
Abstract

The BCL6 proto-oncogene encodes a transcriptional repressor that is required for germinal center (GC) formation and whose de-regulation is involved in lymphomagenesis. Although substantial evidence indicates that BCL6 exerts its function by repressing the transcription of hundreds of protein-coding genes, its potential role in regulating gene expression via MicroRNAs (miRNAs) is not known. We have identified a core of 15 miRNAs that show binding of BCL6 in their genomic loci and are down-regulated in GC B cells. Among BCL6 validated targets, miR-155 and miR-361 directly modulate AID expression, indicating that via repression of these miRNAs, BCL6 up-regulates AID. Similarly, the expression of additional genes relevant for the GC phenotype, including SPI1, IRF8, and MYB, appears to be sustained via BCL6-mediated repression of miR-155. These findings identify a novel mechanism by which BCL6, in addition to repressing protein coding genes, promotes the expression of important GC functions by repressing specific miRNAs.

Figures